Literature DB >> 11158611

CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis.

S P Fling1, R A Sutherland, L N Steele, B Hess, S E D'Orazio, J Maisonneuve, M F Lampe, P Probst, M N Starnbach.   

Abstract

During infection with Chlamydia trachomatis, CD8(+) T cells are primed, even though the bacteria remain confined to a host cell vacuole throughout their developmental cycle. Because CD8(+) T cells recognize antigens processed from cytosolic proteins, the Chlamydia antigens recognized by these CD8(+) T cells very likely have access to the host cell cytoplasm during infection. The identity of these C. trachomatis proteins has remained elusive, even though their localization suggests they may play important roles in the biology of the organism. Here we use a retroviral expression system to identify Cap1, a 31-kDa protein from C. trachomatis recognized by protective CD8(+) T cells. Cap1 contains no strong homology to any known protein. Immunofluorescence microscopy by using Cap1-specific antibody demonstrates that this protein is localized to the vacuolar membrane. Cap1 is virtually identical among the human C. trachomatis serovars, suggesting that a vaccine incorporating Cap1 might enable the vaccine to protect against all C. trachomatis serovars. The identification of proteins such as Cap1 that associate with the inclusion membrane will be required to fully understand the interaction of C. trachomatis with its host cell.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158611      PMCID: PMC14725          DOI: 10.1073/pnas.98.3.1160

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis.

Authors:  A Shor; J I Phillips
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

Review 2.  The novel mechanism of initiation of picornavirus RNA translation.

Authors:  R J Jackson; M T Howell; A Kaminski
Journal:  Trends Biochem Sci       Date:  1990-12       Impact factor: 13.807

Review 3.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

4.  Immunization against scrub typhus. II. Preparation of lyophilized living vaccine.

Authors:  E B JACKSON; J E SMADEL
Journal:  Am J Hyg       Date:  1951-05

5.  Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.

Authors:  P L Earl; S Koenig; B Moss
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

6.  Blasticidin S-resistance gene (bsr): a novel selectable marker for mammalian cells.

Authors:  M Izumi; H Miyazawa; T Kamakura; I Yamaguchi; T Endo; F Hanaoka
Journal:  Exp Cell Res       Date:  1991-12       Impact factor: 3.905

7.  Purification on renografin density gradients of Chlamydia trachomatis grown in the yolk sac of eggs.

Authors:  L Howard; N S Orenstein; N W King
Journal:  Appl Microbiol       Date:  1974-01

8.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

9.  Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.

Authors:  S Chakrabarti; K Brechling; B Moss
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H Su; R P Morrison; N G Watkins; H D Caldwell
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more
  54 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.

Authors:  Chunxue Lu; Hao Zeng; Zhihong Li; Lei Lei; I-Tien Yeh; Yimou Wu; Guangming Zhong
Journal:  Vaccine       Date:  2011-11-10       Impact factor: 3.641

3.  Chlamydial antigens colocalize within IncA-laden fibers extending from the inclusion membrane into the host cytosol.

Authors:  W J Brown; Y A W Skeiky; P Probst; D D Rockey
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

4.  A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis.

Authors:  Sandra Muschiol; Leslie Bailey; Asa Gylfe; Charlotta Sundin; Kjell Hultenby; Sven Bergström; Mikael Elofsson; Hans Wolf-Watz; Staffan Normark; Birgitta Henriques-Normark
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

5.  Development of secondary inclusions in cells infected by Chlamydia trachomatis.

Authors:  Robert J Suchland; Daniel D Rockey; Sara K Weeks; Damir T Alzhanov; Walter E Stamm
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Localization of the hypothetical protein Cpn0585 in the inclusion membrane of Chlamydia pneumoniae-infected cells.

Authors:  Jianhua Luo; Tianjun Jia; Youmin Zhong; Ding Chen; Rhonda Flores; Guangming Zhong
Journal:  Microb Pathog       Date:  2007-01-22       Impact factor: 3.738

7.  Hypothetical protein Cpn0308 is localized in the Chlamydia pneumoniae inclusion membrane.

Authors:  Jianhua Luo; Tianjun Jia; Rhonda Flores; Ding Chen; Guangming Zhong
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

8.  Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers.

Authors:  Gijsbert M Grotenbreg; Nadia R Roan; Eduardo Guillen; Rob Meijers; Jia-Huai Wang; George W Bell; Michael N Starnbach; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-01       Impact factor: 11.205

9.  A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.

Authors:  Jie Wang; Lili Chen; Fan Chen; Xiaoyun Zhang; Yingqian Zhang; Joel Baseman; Sondra Perdue; I-Tien Yeh; Rochelle Shain; Martin Holland; Robin Bailey; David Mabey; Ping Yu; Guangming Zhong
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

10.  Endogenous processing and presentation of T-cell epitopes from Chlamydia trachomatis with relevance in HLA-B27-associated reactive arthritis.

Authors:  Juan J Cragnolini; Noel García-Medel; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2009-05-13       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.